The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.

The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

The Centers for Disease Control and Prevention has issued updated advice on the COVID-19 vaccine days after Health and Human ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

NB.1.8.1 is a variation of the JN.1 COVID variant, which is from the Omicron family. “It doesn’t seem to be a huge jump, like ...

While RFK Jr. said the coronavirus vaccine would be removed from the CDC schedule for healthy children, it’s still ...